Home › Drugmaker GSK sees earnings growth returning in 2016
 

Keywords :   


Drugmaker GSK sees earnings growth returning in 2016

2015-07-29 15:23:07| Biotech - Topix.net

Britain-based drugmaker GlaxoSmithKline has reported a drop in earnings in the first full quarter since its deal to swap some assets with Swiss rival Novartis. Second-quarter net income fell to 149 million pounds from 654 million pounds a year earlier, while sales rose 6 percent to 5.89 billion pounds.

Tags: growth returning sees earnings

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
11.05Naples Soap Company Reports Revenue Surge Amidst Tourist Season
11.05Indian Perfume Brand Eze Perfumes Enters US Market
11.05LOccitane Travel Retail Showcases Travel Retail Brand Portfolio at TFWA Asia Pacific
10.05How crops are being disaster-proofed
10.05'I got married on a Thursday and saved 3,000'
10.05Inland Packaging receives Molson Coors Packaging Supplier of the Year
10.05Delays warning as M25 stretch closes for the weekend
10.05AAPI-Owned Three Ships Beauty Raises $2.5 Million
More »